Skip to main content
. 2024 Jan 9;25(2):832. doi: 10.3390/ijms25020832

Figure 2.

Figure 2

Longer small intestinal and colon length in Nlgn3R451C mice. (A) Wild-type (WT; n = 21) and Nlgn3R451C (n = 24) small intestinal (SI) gut length in the active state (control) and after incubation in 100 µM of the muscle relaxant nicardipine (* p > 0.05 two-way ANOVA test (variables tested: genotype and nicardipine treatment), Sidak correction). Normality assumptions passed (Shapiro–Wilk normality of residuals test: w = 0.98, p = 0.3). (B) Increased colon length in Nlgn3R451C mice (n = 28) compared to wild-type mice (n = 13) (Student’s t-test. * p > 0.05). Normality assumptions passed (Shapiro–Wilk normality test WT: w = 0.95, p = 0.7; Nlgn3R451C: w = 0.9, p = 0.1). (C) No differences were observed between the body weights in a sample of WT (n = 21) and Nlgn3R451C mice (n = 24) (Student’s t-test. * p = 0.17). Normality assumptions passed (Shapiro–Wilk normality test WT: w = 0.97, p = 0.6; Nlgn3R451C: w = 0.98, p = 0.9). ns: not statistically significant.